New ulcerative colitis drug enters first human safety tests
NCT ID NCT07526519
First seen Apr 22, 2026 · Last updated May 12, 2026 · Updated 2 times
Summary
This early-stage study is testing a new drug, TL-003, to see if it is safe and how the body processes it. The study first involves healthy adults, then a small group of people with ulcerative colitis. The main goal is to check for side effects and measure drug levels in the blood.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Linear Early Phase Ltd
RECRUITINGPerth, Western Australia, 6009, Australia
Conditions
Explore the condition pages connected to this study.